Trump's proposed border tax to hit domestic pharma companies: Report
The domestic pharma companies are likely to be impacted and may see a rough road ahead in the US if the Trump administration decides to implement the proposed border adjustment tax (BAT), says a report.
Mar 17, 2017, 00:00 AM IST